NI
UTHR icon

NDVR Inc’s United Therapeutics UTHR Stock Holding History

NDVR Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$300K Buy
616
+30
+5% +$14K 0.25% 57
2025
Q3 		$246K Buy
+586
New +$197K 0.2% 82
2025
Q2 		– Sell
-681
Closed -$210K – 110
2025
Q1 		$210K Buy
681
+37
+6% +$12.7K 0.21% 96
2024
Q4 		$227K Buy
644
+66
+11% +$24.3K 0.22% 87
2024
Q3 		$207K Buy
+578
New +$195K 0.21% 97

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

NDVR Inc's UTHR Position: Q4 2025 in Review

NDVR Inc increased its United Therapeutics (UTHR) stake by 5.1% in Q4 2025, buying an estimated $14K and bringing the position to 616 shares worth $300K. The position accounts for 0.25% of the portfolio, ranked #57.

NDVR Inc first reported a position in UTHR in Q3 2024 and has held it in 5 quarters since. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • NDVR Inc held 616 shares of United Therapeutics worth $300K as of Q4 2025.
  • NDVR Inc bought 30 United Therapeutics shares in Q4 2025, an estimated $14K.
  • United Therapeutics made up 0.25% of NDVR Inc's portfolio in Q4 2025, its #57 holding.
  • NDVR Inc first reported a position in United Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on NDVR Inc's 13F filing for Q4 2025, filed 12 Feb 2026.